Department of Immunology and Oncode Institute, Leiden University Medical Center, Leiden, Netherlands.
Aduro Biotech Europe BV, Oss, Netherlands.
Front Immunol. 2020 Oct 6;11:592569. doi: 10.3389/fimmu.2020.592569. eCollection 2020.
Persistent antigen exposure in chronic infection and cancer has been proposed to lead to cytotoxic T lymphocyte (CTL) "exhaustion", i.e., loss of effector function and disease control. Recent work identifies a population of poorly differentiated TCF-1PD-1 CD8 T cells as precursors of the terminally exhausted CTL pool. These "predysfunctional" CTLs are suggested to respond to PD-1 targeted therapy by giving rise to a pool of functional CTLs. Supported by gene expression analyses, we present a model in which lack of CD4 T cell help during CD8 T cell priming results in the formation of predysfunctional CTLs. Our model implies that predysfunctional CTLs are formed during priming and that the remedy for CTL dysfunction is to provide "help" signals for generation of optimal CTL effectors. We substantiate that this may be achieved by engaging CD4 T cells in new CD8 T cell priming, or by combined PD-1 blocking and CD27 agonism with available immunotherapeutic antibodies.
慢性感染和癌症中持续的抗原暴露被认为会导致细胞毒性 T 淋巴细胞 (CTL)“耗竭”,即效应功能丧失和疾病控制。最近的研究工作确定了一群分化不良的 TCF-1PD-1 CD8 T 细胞作为终末耗竭 CTL 池的前体细胞。这些“预功能性失调”的 CTL 被认为通过产生功能性 CTL 池对 PD-1 靶向治疗有反应。我们提出了一个模型,即 CD8 T 细胞初始阶段缺乏 CD4 T 细胞辅助会导致预功能性 CTL 的形成。我们的模型表明,预功能性 CTL 是在初始阶段形成的,CTL 功能障碍的补救措施是提供“帮助”信号以产生最佳 CTL 效应器。我们证实,这可以通过使 CD4 T 细胞参与新的 CD8 T 细胞初始或通过结合 PD-1 阻断和 CD27 激动剂与现有的免疫治疗抗体来实现。